Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

23.71

-0.09 (-0.38%)

At close: Aug 13, 2026, 4:00 PM EDT

23.66

-0.05 (-0.21%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Seaport Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-134.69	-74.88	-46.88
Depreciation & Amortization	0.15	0.17	0.17
Stock-Based Compensation	42.94	6.88	14.52
Other Adjustments	-0.7	-2.19	0.05
Changes in Accounts Payable	3.5	-3.07	2.07
Changes in Accrued Expenses	2.78	3.95	0.92
Changes in Other Operating Activities	-2.72	-8.81	-0.48
Operating Cash Flow	-88.73	-77.94	-29.63
Operating Cash Flow Growth	-	-	-
Capital Expenditures	-0.03	-0.36	-0.11
Purchases of Investments	-392.87	-396.39	-
Proceeds from Sale of Investments	260	212.5	-
Investing Cash Flow	-132.9	-184.25	-0.11
Issuance of Common Stock	0.81	0	-
Net Common Stock Issued (Repurchased)	0.81	0	-
Issuance of Preferred Stock	-	-	326.1
Net Preferred Stock Issued (Repurchased)	-	-	326.1
Other Financing Activities	-	-0.87	13.2
Financing Cash Flow	239.27	-0.87	339.3
Foreign Exchange Rate Adjustments	0	0	-
Net Cash Flow	17.65	-263.06	309.55
Free Cash Flow	-88.76	-78.3	-29.74
Free Cash Flow Growth	-	-	-
Free Cash Flow Per Share	-8.35	-32.98	-31.54
Levered Free Cash Flow	-131.01	-82.99	-44.31
Unlevered Free Cash Flow	-143.82	-96.32	-49.85

SEC Filings: 10-K · 10-Q